ArticleslgStudy

chemistry

Sebetralstat

Sebetralstat is a chemistry topic covered in the lgStudy science library. This page brings together a partial reference excerpt, illustrations, worked examples, real-world applications and a short study plan, so you can understand Sebetralstat rather than just read about it. In short: Sebetralstat, sold under the brand name Ekterly, is a medication used for the treatment of hereditary angioedema. Sebetralstat is a plasma kallikrein inhibitor that suppresses the activation of the positive feedback mechanism of the kallikrein-kinin system, thereby reducing factor XIIa and additional plasma kallikrein production.

Sebetralstat — main illustration
Sebetralstat — illustration

Key takeaways

  • Sebetralstat belongs to chemistry; place it in that map before memorising details.
  • Learn the definition first, then one example that makes the definition concrete.
  • Connect Sebetralstat to a quantity you can measure, compute or draw — that is where exam questions come from.
  • Reproduce the core statement of Sebetralstat from memory before moving on to harder problems.

Reference excerpt

Sebetralstat, sold under the brand name Ekterly, is a medication used for the treatment of hereditary angioedema. Sebetralstat is a plasma kallikrein inhibitor that suppresses the activation of the positive feedback mechanism of the kallikrein-kinin system, thereby reducing factor XIIa and additional plasma kallikrein production. By inhibiting plasma kallikrein, sebetralstat reduces the production of bradykinin, thereby halting the progression of hereditary angioedema attacks. It is taken by mouth. The most common side effect is headache. Sebetralstat was approved for medical use in the United States in July 2025, and in the European Union in September 2025.

Medical uses Sebetralstat is indicated for the treatment of acute attacks of hereditary angioedema.

Pharmacology Sebetralstat is a plasma kallikrein inhibitor that contains the unusual 2-pyridone heterocycle.

History The US Food and Drug Administration (FDA) approved sebetralstat based on evidence from a clinical trial (KONFIDENT) that enrolled 110 participants with hereditary angioedema type I or II. The trial was conducted at 66 sites in 20 countries, including Australia, Bulgaria, Canada, France, Germany, Greece, Hungary, Israel, Italy, Japan, Netherlands, New Zealand, North Macedonia, Poland, Portugal, Romania, Slovakia, Spain, the United Kingdom, and the United States. In the study, participants tried three different treatments in random order: sebetralstat 600 mg, sebetralstat 300 mg, and a placebo (inactive pill that looks like the real medicine). The main goal of the study was to measure how quickly sebetralstat started working. Researchers tracked how long it took for people to feel at least "a little better" twice in a row within twelve hours of taking their first dose.

Society and culture

Legal status Sebetralstat was approved for medical use in the United States in July 2025. The US Food and Drug Administration granted the application for sebetralstat orphan drug designation. In July 2025, the Committee for Medicinal Products for Human Use of the European Medicines Agency adopted a positive opinion, recommending the granting of a marketing authorization for the medicinal product Ekterly, intended for the symptomatic treatment of acute attacks of hereditary angioedema in people aged twelve years of age and older. The applicant for this medicinal product is KalVista Pharmaceuticals (Ireland) Ltd. Hereditary angioedema is a rare, chronic, genetic, debilitating, and potentially life-threatening disorder characterized by recurrent and often unpredictable attacks of swelling in many parts of the body. This is the first oral treatment for hereditary angioedema recommended for approval in the European Union. Sebetralstat was authorized for medical use in the European Union in September 2025.

Names Sebetralstat is the international nonproprietary name. Sebetralstat is sold under the brand name Ekterly.

References

External links "Sebetralstat (Code - C184930)". EVS Explore. Clinical trial number NCT05259917 for "A Phase III, Crossover Trial Evaluating the Efficacy and Safety of KVD900 (Sebetralstat) for On-Demand Treatment of Angioedema Attacks in Adolescent and Adult Patients With Hereditary Angioedema (HAE)" at ClinicalTrials.gov

Illustrations

Sebetralstat illustration

Worked examples

Example 1 — a first encounter with Sebetralstat

Start with the simplest possible case. Write down what Sebetralstat claims or describes in one sentence, then invent the smallest concrete situation in which that sentence is true. In chemistry, the smallest case is usually a single object, a single equation or a single measurement. Check that every symbol or term in your sentence has a meaning in that case.

Example 2 — changing one variable

Take the situation from Example 1 and change exactly one quantity: double it, halve it, or set it to zero. Predict what should happen to Sebetralstat before you calculate. Comparing your prediction with the result is the fastest way to find out whether you understand the idea or only the words.

Example 3 — an exam-style question

Typical questions about Sebetralstat ask you to (a) state it precisely, (b) apply it to given data, and (c) explain a limitation. Practise writing all three answers in under five minutes; the third part is what separates a full-mark answer from an average one.

Applications of Sebetralstat

In research
Sebetralstat appears in chemistry research whenever the underlying quantities have to be modelled precisely. Papers usually cite it as a starting assumption and then explore where it breaks down.
In technology and industry
Engineering practice reuses Sebetralstat in design rules, simulations and safety margins. Knowing the idea lets you read a specification sheet and understand why the numbers look the way they do.
In the classroom
Sebetralstat is common in secondary-school and first-year university syllabi. It links to neighbouring topics 2-Pyridones, Carboxamides, Fluoroarenes, so understanding it makes those chapters shorter.
In everyday life
Look for Sebetralstat outside the textbook — in sport, cooking, traffic, electronics or the sky above you. An example you found yourself is remembered far longer than one you were given.

Affiliate

Preply — study more efficiently by working with a personal tutor. 50% off.

How to study Sebetralstat in 20 minutes

  1. Read the reference excerpt below once, without taking notes.
  2. Close the page and write down what Sebetralstat means in your own words.
  3. Compare your version with the excerpt and mark what you missed.
  4. Work through the three examples above with pen and paper.
  5. Explain Sebetralstat out loud to somebody else — or to Teacher Smith in the lgStudy chat.

Frequently asked questions

What is Sebetralstat in simple terms?

Sebetralstat, sold under the brand name Ekterly, is a medication used for the treatment of hereditary angioedema. Sebetralstat is a plasma kallikrein inhibitor that suppresses the activation of the positive feedback mechanism of the kallikrein-kinin system, thereby reducing factor XIIa and addition…

Why does Sebetralstat matter?

Because it connects several chemistry ideas at once: it gives you a definition you can apply, a quantity you can calculate, and a way to check whether a result is plausible.

How should I study Sebetralstat?

Read the excerpt, restate it from memory, then work through the examples and applications listed on this page. The five-step study plan above takes about twenty minutes.

What does this page cover?

It gives you a compact reference excerpt plus original lgStudy explanations, examples, applications and study material on Sebetralstat.

Tags

  • 2-Pyridones
  • Carboxamides
  • Fluoroarenes
  • Methoxy compounds
  • Orphan drugs
  • Pyrazoles
  • Pyridines

Keep exploring